213 related articles for article (PubMed ID: 31764853)
21. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance of miR-1826 as a Novel Prognostic Biomarker in Colorectal Cancer.
Hu Y; Yi B; He S; Gao L; Liu P; Wang L; Yu J; Wan D; Zhou J; Zhu X; Zhi Q
Anticancer Agents Med Chem; 2016; 16(9):1109-16. PubMed ID: 25968874
[TBL] [Abstract][Full Text] [Related]
23. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
24. Plasma microRNA-1207-5p as a Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.
Wang X; Li L; Xiao W; Xu Q
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902212
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic potential of miR-196a-1 in colorectal cancer.
Mehrjoei B; Haghnazari L; Bashiri H; Rezvani N
BMC Cancer; 2024 Feb; 24(1):162. PubMed ID: 38302924
[TBL] [Abstract][Full Text] [Related]
26. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G; Razavi AE; Pakzad I; Malayeri FA
Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
[TBL] [Abstract][Full Text] [Related]
29. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
34. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
Zheng GX; Qu AL; Yang YM; Zhang X; Zhang SC; Wang CX
World J Gastroenterol; 2016 Jun; 22(24):5589-97. PubMed ID: 27350737
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
[TBL] [Abstract][Full Text] [Related]
36. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
37. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
38. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
[TBL] [Abstract][Full Text] [Related]
39. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
40. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
